Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Children With Complicated Slow-flow Vascular Malformations
NCT02509468Phase 2Completed
- Sponsor
- University Hospital Tours
- Start
- Sep 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sirolimus in vascular malformation (2 arms), sponsored by University Hospital Tours. Primary endpoint: Change of volume of the Vascular Malformation at 12 months. Started Sep 2015; status: completed.
02
Drugs
sirolimus
03
Conditions
vascular malformation
Beyond the preview
Go deeper on NCT02509468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509468.